Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

The Chinese University of Hong Kong

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1963-01-01

Employees: -

Market Cap: -

Website: http://www.cuhk.edu.hk

Clinical Trials

Trial of Hepaguard® in Adults With Nonalcoholic Steatohepatitis

Not Applicable

Completed

Conditions: Nonalcoholic Fatty Liver Disease

Interventions: Drug: Placebo
Drug: Phyllanthus urinaria

First Posted Date: 2010-09-29

Last Posted Date: 2014-02-24

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 60

Registration Number: NCT01210989

Locations: 🇨🇳
Cheng Suen Man Shook Hepatitis Center, Institute of Digestive Disease, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China

Long-Acting Tacrolimus for the Treatment of Resistant Lupus Nephritis

Phase 4

Completed

Conditions: Lupus Nephritis

Interventions: Drug: Long-acting tacrolimus (Advagraf, Astellas Pharma)

First Posted Date: 2010-09-22

Last Posted Date: 2012-12-04

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 2

Registration Number: NCT01206569

Locations: 🇭🇰
Prince of Wales Hospital, Shatin, Hong Kong

A Randomised Controlled Trial on LESS Versus Conventional Laparoscopic Appendicectomy.

Phase 3

Completed

Conditions: Appendicitis

Interventions: Procedure: LESS appendectomy
Procedure: Conventional 3-port laparoscopic appendectomy

First Posted Date: 2010-09-16

Last Posted Date: 2011-07-21

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 200

Registration Number: NCT01203566

Locations: 🇨🇳
Deparment of Surgery, North District Hospital, Sheung Shui, Hong Kong, China
🇨🇳
Department of Surgery, Prince of Wales Hospital, Shatin, Hong Kong, China

PPI vs H2RA in Patients With Helicobacter Pylori-Negative Idiopathic Bleeding Ulcers

Phase 4

Completed

Conditions: Peptic Ulcer

Interventions: Drug: Famotidine
Drug: Lansoprazole

First Posted Date: 2010-08-12

Last Posted Date: 2019-08-01

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 228

Registration Number: NCT01180179

Locations: 🇨🇳
Endoscopy Center, Prince of Wales Hospital, Shatin, Hong Kong, China

To Assess the Accuracy of the eZscan Study in the Screening for Diabetic Nephropathy

Completed

Conditions: Diabetic Nephropathy

First Posted Date: 2010-07-16

Last Posted Date: 2015-10-12

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 100

Registration Number: NCT01163591

Locations: 🇨🇳
Diabetes Mellitus and Endocrine Centre, Prince of Wales Hospital, Shatin, Hong Kong, China

PET-CT and Circulating Tumor Cells in Colorectal Cancer

Completed

Conditions: Colorectal Cancer
Metastasis

Interventions: Drug: Chemotherapy

First Posted Date: 2010-07-15

Last Posted Date: 2017-05-08

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 84

Registration Number: NCT01163305

Locations: 🇭🇰
Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong, Hong Kong

Cincalcet and Vascular Arterial Stiffness Among Peritoneal Dialysis Patients With Secondary Hyperparathyroidism

Phase 4

Completed

Conditions: Hyperparathyroidism
Arterial Stiffness

Interventions: Drug: Cinacalcet

First Posted Date: 2010-06-15

Last Posted Date: 2013-11-13

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 44

Registration Number: NCT01143987

Locations: 🇭🇰
Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong

The Patency Period of the New Plastic Anti-reflux Biliary Stent

Not Applicable

Terminated

Conditions: Cholangitis
Pancreatitis

Interventions: Device: Anti-reflux Tannenbaum biliary stent
Device: Ordinary Tannenbaum biliary stent

First Posted Date: 2010-06-14

Last Posted Date: 2017-04-21

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 16

Registration Number: NCT01142921

Locations: 🇨🇳
Endoscopy Centre, Hong Kong, China

Effect of IV and Oral Esomeprazole in Prevention of Recurrent Bleeding From Peptic Ulcers After Endoscopic Therapy

Phase 3

Completed

Conditions: Peptic Ulcer
Bleeding

Interventions: Drug: Oral esomeprazole
Drug: Intravenous Esomeprazole

First Posted Date: 2010-06-11

Last Posted Date: 2015-08-13

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 263

Registration Number: NCT01142245

Locations: 🇨🇳
Endoscopy Center in Prince of Wales Hospital, Hong Kong (SAR), China
🇨🇳
Endoscopy Centre, Hong Kong, China

Early Selective TAE to Severely Bleeding Peptic Ulcers After Their Initial Endoscopic Hemostasis

Not Applicable

Completed

Conditions: Arterial Embolization
Peptic Ulcer
Bleeding

Interventions: Procedure: No TAE
Procedure: TAE

First Posted Date: 2010-06-11

Last Posted Date: 2018-07-18

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 258

Registration Number: NCT01142180

Locations: 🇨🇳
Endoscopy Centre, Prince of Wales Hospital, Hong Kong, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy